Results 51 to 60 of about 27,818 (210)

Introduction and evolution of dengue virus type 2 in Pakistan: a phylogeographic analysis [PDF]

open access: yes, 2015
Discrete Bayes Factors from SPREAD. Locations are denoted with two letter codes (Additional file 5: Table S3). The upper half of the matrix shows the mean (standard deviation) for the discrete Bayes Factor calculated for the 12 discrete trait models. The
Amanda Sue   +8 more
core   +4 more sources

The biological role of Asn-linked glycosylations of DENV-2 E protein [PDF]

open access: yes, 2008
The envelope proteins of many viruses are glycosylated, where the glycans on the virion surface have been shown to be important, in addition to their strictly structural role, in various aspects of the virus life cycle, such as receptor-binding and ...
Leang, Sook Kwan
core   +1 more source

The reintroduction of DENV-2 in 2011 in Panama and subsequent outbreak characteristic [PDF]

open access: yesActa Tropica, 2018
The circulation of the South-east Asian/American (AS/AM) dengue 2 virus (DENV-2) genotype in the Americas has been associated with a high rate of severe disease. From 1993, the year DENV was reintroduced in Panama, until 2011 there were 29 dengue-associated deaths, 17 of which occurred in 2011, the most severe outbreak with a case fatality rate (CFR ...
Yamilka, Díaz   +16 more
openaire   +2 more sources

Augmentation of 5-lipoxygenase activity and expression during dengue serotype-2 infection [PDF]

open access: yes, 2013
published_or_final_versio
Chow, AY   +8 more
core   +1 more source

Dengue virus neutralizing antibody levels associated with protection from infection in thai cluster studies. [PDF]

open access: yesPLoS Neglected Tropical Diseases, 2014
Long-term homologous and temporary heterologous protection from dengue virus (DENV) infection may be mediated by neutralizing antibodies. However, neutralizing antibody titers (NTs) have not been clearly associated with protection from infection.Data ...
Darunee Buddhari   +13 more
doaj   +1 more source

Endurance, Refuge, and Reemergence of Dengue Virus Type 2, Puerto Rico, 1986–2007

open access: yesEmerging Infectious Diseases, 2011
To study the evolution of dengue virus (DENV) serotype 2 in Puerto Rico, we examined the genetic composition and diversity of 160 DENV-2 genomes obtained through 22 consecutive years of sampling.
Kate L. McElroy   +5 more
doaj   +1 more source

On the Dynamics of Dengue Virus type 2 with Residence Times and Vertical Transmission

open access: yes, 2016
A two-patch mathematical model of Dengue virus type 2 (DENV-2) that accounts for vectors' vertical transmission and between patches human dispersal is introduced. Dispersal is modeled via a Lagrangian approach.
Bichara, Derdei   +4 more
core   +2 more sources

Natural Products as Source of Potential Dengue Antivirals [PDF]

open access: yes, 2014
Dengue is a neglected disease responsible for 22,000 deaths each year in areas where it is endemic. To date, there is no clinically approved dengue vaccine or antiviral for human beings, even though there have been great efforts to accomplish these goals.
Adalberto da Silva   +21 more
core   +4 more sources

Emergence of genotype Cosmopolitan of dengue virus type 2 and genotype III of dengue virus type 3 in Thailand. [PDF]

open access: yesPLoS ONE, 2018
Dengue is a mosquito-borne disease that has spread to over 100 countries. Dengue fever is caused by dengue virus (DENV), which belongs to the Flavivirus genus of the family Flaviviridae. DENV comprises 4 serotypes (DENV-1 to DENV-4), and each serotype is
Juthamas Phadungsombat   +8 more
doaj   +1 more source

Arboviruses and the challenge to establish systemic and persistent infections in competent mosquito vectors : the interaction with the RNAi mechanism [PDF]

open access: yes, 2019
Arboviruses are capable to establish long-term persistent infections in mosquitoes that do not affect significantly the physiology of the insect vectors. Arbovirus infections are controlled by the RNAi machinery via the production of viral siRNAs and the
Kolliopoulou, Anna   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy